Evaluation of Fruquintinib in the Continuum of Care of Patients with Colorectal Cancer

The management of patients with metastatic colorectal cancer (mCRC) has the continuum of care as the treatment paradigm. To date, trifluridine/tipiracil, a biochemically modulated fluoropyrimidine, and regorafenib, a multi-kinase inhibitor, remain the main options for the majority of patients who pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Lavacchi, Daniele, Roviello, Giandomenico, Guidolin, Alessia, Romano, Silvia, Venturini, Jacopo, Caliman, Enrico, Vannini, Agnese, Giommoni, Elisa, Pellegrini, Elisa, Brugia, Marco, Pillozzi, Serena, Antonuzzo, Lorenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10051170/
https://www.ncbi.nlm.nih.gov/pubmed/36982913
http://dx.doi.org/10.3390/ijms24065840

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10051170/
https://www.ncbi.nlm.nih.gov/pubmed/36982913
http://dx.doi.org/10.3390/ijms24065840

Ejemplares similares